TCR alpha beta/CD19 DEPLETED HAPLO-HSCT plus ZOLEDRONATE FOR PEDIATRIC MALIGNANCIES: PRELIMINARY FINDINGS

Pytel, N; McDowell, K; Desantes, K; Capitini, C; Hematti, P; Leith, C; Sondel, P; Otto, M

PEDIATRIC BLOOD & CANCER, 2019; 66 ():